Thursday - July 9, 2026

CASTLEVAX Wins $398,973,027 Federal Contract

WASHINGTON, Sept. 29 -- CASTLEVAXNew York won a federal contract award for $398,973,027 from the Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response for research and development in biotechnology (except nanobiotechnology). The document states about the contract: phase 2b clinical trial to develop a next-generation, mucosally delivered, covid-19 booster vaccine capable of eliciting mucosal immunity and protecting against sars-cov-2 breakthrough infe . . .

Targeted News Service Information Request Form

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization Name:
Email:
Phone:
State:
I'd like to have a copy of this article mailed to me.

Request a free sample

Check any of the products below to receive a free sample via email.
1 - State Newsletters
2 - Federal Contract Awards
3 - Federal Solicitations (by product/service) **
4 - Federal Grant Opportunities (by eligible recipient/topic category) **
5 - U.S. Patent Awards
Check the products below that interest you and a representative will be in touch shortly.
5 - U.S. Patent Awards
6 - Congressional Votes (by state delegation)
7 - NewsFocus Newsletter (by YOUR subject topic) **
8 - Congressional Bill Introductions
9 - Customized services (we'll be in touch by phone) **
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest.
If you select them please specify your keywords in the box below:

Additonal questions or comments:



Contact: Kathleen Sears

Copyright Targeted News Service 2023